Login / Signup

Targeting IL-6 in COVID-19. Response to: 'Rational use of tocilizumab in COVID-19' by Jain and Sharma.

Pier Leopoldo CapecchiPietro Enea Lazzerini
Published in: Annals of the rheumatic diseases (2020)
Keyphrases
  • coronavirus disease
  • sars cov
  • rheumatoid arthritis
  • juvenile idiopathic arthritis
  • cancer therapy
  • rheumatoid arthritis patients
  • drug delivery
  • disease activity